lixivaptan has been researched along with deamino arginine vasopressin in 2 studies
| Studies (lixivaptan) | Trials (lixivaptan) | Recent Studies (post-2010) (lixivaptan) | Studies (deamino arginine vasopressin) | Trials (deamino arginine vasopressin) | Recent Studies (post-2010) (deamino arginine vasopressin) |
|---|---|---|---|---|---|
| 80 | 10 | 26 | 4,396 | 516 | 1,016 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Centrone, M; Di Mise, A; Pellegrini, L; Ranieri, M; Tamma, G; Valenti, G; Venneri, M | 1 |
| Decaux, G | 1 |
2 other study(ies) available for lixivaptan and deamino arginine vasopressin
| Article | Year |
|---|---|
Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells.
Topics: Animals; Aquaporin 2; Benzamides; Cell Line; Deamino Arginine Vasopressin; Diuretics; Gene Expression Regulation; Kidney Tubules, Collecting; Mice; Phosphorylation; Pyrroles; Receptors, Vasopressin; Signal Transduction | 2019 |
Low Creatininuria due to Hyponatremia Is Reversible in Many Patients.
Topics: Adult; Aged; Benzamides; Creatinine; Deamino Arginine Vasopressin; Female; Humans; Hyponatremia; Male; Middle Aged; Pyrroles; Retrospective Studies | 2022 |